Literature DB >> 1763025

Xenotransplantation of canine, bovine, and porcine islets in diabetic rats without immunosuppression.

R P Lanza1, D H Butler, K M Borland, J E Staruk, D L Faustman, B A Solomon, T E Muller, R G Rupp, T Maki, A P Monaco.   

Abstract

Permselective acrylic membranes were employed to prevent immune rejection of discordant islet xenografts isolated from various large animals. Canine, porcine, and bovine islets were seeded into tubular diffusion chambers and transplanted into the peritoneum of 27 nonimmunosuppressed streptozotocin-induced diabetic Lewis rats. Six recipients received islet grafts from bovine calves, 7 received grafts from pigs, and 14 received grafts from dogs. Four of the latter were removed at 1 month. In the control group of 10 diabetic rats, 4 received nonencapsulated canine islets, 3 received nonencapsulated bovine islets, and 3 received nonencapsulated porcine islets. Recipients of encapsulated islets promptly dropped from a pretransplantation plasma glucose level of 487 +/- 36 (mean +/- SEM) to 84 +/- 2 (canine), 81 +/- 4 (bovine), and 81 +/- 3 mg/dl (porcine) during the first week. All of the animals sustained these levels for at least 1 month. One rat spontaneously reverted to diabetes at 54 days posttransplantation; 4 other rats became hyperglycemic (glucose, greater than 600 mg/dl) after membrane removal on day 30. The remaining 22 rats maintained fasting euglycemia for greater than 10 weeks. In contrast, rats that received nonencapsulated islets became hyperglycemic in less than 7 days. Intravenous glucose tolerance test K values (decline in glucose levels, %/min) at 1 month for the canine and bovine encapsulated islet transplant group were 3.5 +/- 0.3 and 3.3 +/- 0.1 compared with 3.3 +/- 0.1 (P = 0.63) and 0.91 +/- 0.1 (P less than 0.0001) for normal (n = 4) and diabetic (n = 4) control groups. Morphologic studies of long-term functioning grafts (30-130 days) revealed well-preserved alpha, beta, and delta cells, with varying degrees of granulation. These results demonstrate that immune isolation of islet tissue using permselective artificial membranes can protect discordant islet xenografts from immune rejection in the absence of any immunosuppressive drugs.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1763025      PMCID: PMC53081          DOI: 10.1073/pnas.88.24.11100

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  25 in total

1.  RELATIONSHIP BETWEEN INTRAVENOUS GLUCOSE TOLERANCE AND THE FASTING BLOOD GLUCOSE LEVEL IN HEALTHY AND IN DIABETIC SUBJECTS.

Authors:  J A MOORHOUSE; G R GRAHAME; N J ROSEN
Journal:  J Clin Endocrinol Metab       Date:  1964-02       Impact factor: 5.958

Review 2.  Xenogeneic transplantation. A review.

Authors:  H Auchincloss
Journal:  Transplantation       Date:  1988-07       Impact factor: 4.939

3.  Detection of T and B cell antigens hybridoma monoclonal antibodies: a biotin-avidin-horseradish peroxidase method.

Authors:  R Warnke; R Levy
Journal:  J Histochem Cytochem       Date:  1980-08       Impact factor: 2.479

4.  High-performance liquid chromatography analysis of circulating insulins distinguishes between endogenous insulin production (a potential pitfall with streptozotocin diabetic rats) and islet xenograft function.

Authors:  D Chicheportiche; S Darquy; J Lepeintre; F Capron; P A Halban; G Reach
Journal:  Diabetologia       Date:  1990-08       Impact factor: 10.122

5.  Long-term plasma glucose normalization in experimental diabetic rats with macroencapsulated implants of benign human insulinomas.

Authors:  J J Altman; D Houlbert; P Callard; P McMillan; B A Solomon; J Rosen; P M Galletti
Journal:  Diabetes       Date:  1986-06       Impact factor: 9.461

6.  Bioartificial pancreas in autoimmune nonobese diabetic mice.

Authors:  J J Altman; A Penfornis; J Boillot; M Maletti
Journal:  ASAIO Trans       Date:  1988 Jul-Sep

7.  Biohybrid artificial pancreas: long-term implantation studies in diabetic, pancreatectomized dogs.

Authors:  S J Sullivan; T Maki; K M Borland; M D Mahoney; B A Solomon; T E Muller; A P Monaco; W L Chick
Journal:  Science       Date:  1991-05-03       Impact factor: 47.728

8.  Autoimmune diabetes in NOD mouse is L3T4 T-lymphocyte dependent.

Authors:  Y Wang; L Hao; R G Gill; K J Lafferty
Journal:  Diabetes       Date:  1987-04       Impact factor: 9.461

9.  Critical mass of purified islets that induce normoglycemia after implantation into dogs.

Authors:  G L Warnock; R V Rajotte
Journal:  Diabetes       Date:  1988-04       Impact factor: 9.461

10.  Destruction of rat islet cell monolayers by cytokines. Synergistic interactions of interferon-gamma, tumor necrosis factor, lymphotoxin, and interleukin 1.

Authors:  C Pukel; H Baquerizo; A Rabinovitch
Journal:  Diabetes       Date:  1988-01       Impact factor: 9.461

View more
  15 in total

Review 1.  Pig-to-Primate Islet Xenotransplantation: Past, Present, and Future.

Authors:  Zhengzhao Liu; Wenbao Hu; Tian He; Yifan Dai; Hidetaka Hara; Rita Bottino; David K C Cooper; Zhiming Cai; Lisha Mou
Journal:  Cell Transplant       Date:  2017-02-03       Impact factor: 4.064

2.  Encapsulated islets transplantation: Past, present and future.

Authors:  Naoaki Sakata; Shoichiro Sumi; Gumpei Yoshimatsu; Masafumi Goto; Shinichi Egawa; Michiaki Unno
Journal:  World J Gastrointest Pathophysiol       Date:  2012-02-15

Review 3.  Treatment of diabetes with encapsulated pig islets: an update on current developments.

Authors:  Hai-tao Zhu; Lu Lu; Xing-yu Liu; Liang Yu; Yi Lyu; Bo Wang
Journal:  J Zhejiang Univ Sci B       Date:  2015-05       Impact factor: 3.066

4.  Role of ATP and Pi in the mechanism of insulin secretion in the mouse insulinoma betaTC3 cell line.

Authors:  K K Papas; R C Long; I Constantinidis; A Sambanis
Journal:  Biochem J       Date:  1997-09-15       Impact factor: 3.857

Review 5.  Engineering the vasculature for islet transplantation.

Authors:  Daniel T Bowers; Wei Song; Long-Hai Wang; Minglin Ma
Journal:  Acta Biomater       Date:  2019-05-23       Impact factor: 8.947

6.  Oxygen generating biomaterial improves the function and efficacy of beta cells within a macroencapsulation device.

Authors:  M M Coronel; J-P Liang; Y Li; C L Stabler
Journal:  Biomaterials       Date:  2019-04-19       Impact factor: 12.479

7.  Engraftment of cells from porcine islets of Langerhans and normalization of glucose tolerance following transplantation of pig pancreatic primordia in nonimmune-suppressed diabetic rats.

Authors:  Sharon A Rogers; Thalachallour Mohanakumar; Helen Liapis; Marc R Hammerman
Journal:  Am J Pathol       Date:  2010-06-25       Impact factor: 4.307

Review 8.  Encapsulated cell grafts to treat cellular deficiencies and dysfunction.

Authors:  N V Krishnamurthy; Barjor Gimi
Journal:  Crit Rev Biomed Eng       Date:  2011

Review 9.  Islet microencapsulation: a review.

Authors:  H A Clayton; R F James; N J London
Journal:  Acta Diabetol       Date:  1993       Impact factor: 4.280

10.  Towards the development of a bioartificial pancreas: immunoisolation and NMR monitoring of mouse insulinomas.

Authors:  A Sambanis; K K Papas; P C Flanders; R C Long; H Kang; I Constantinidis
Journal:  Cytotechnology       Date:  1994       Impact factor: 2.058

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.